Howe AY, Cheng H, Thompson I, Chunduru SK, Herrmann S, OConnell J, Agarwal A, Chopra R, Del Vecchio . Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase i. Antimicrob Agents Chemother . 2006. 50(12) . 4103-4113. Find at Google Scholar.
Shi ST, Herlihy KJ, Graham JP, Fuhrman SA, Doan C, Parge H, Hickey M, Gao J, Yu X, Chau F, Gonzalez . In vitro resistance study of AG-021541, a novel nonnucleoside inhibitor of the hepatitis C virus RNA. Antimicrob Agents Chemother . 2008. 52(2). 675-683. Find at Google Scholar.
Le Pogam S, Kang H, Harris SF, Leveque V, Giannetti AM, Ali S, Jiang WR, Rajyaguru S, Tavares G, Osh. Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonn. J Virol. . 2006. 80(12) . 6146-6154. Find at Google Scholar.
Bartels DJ, Sullivan JC, Zhang EZ, Tigges AM, Dorrian JL, De Meyer S, Takemoto D, Dondero E, Kwong A. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely. J Virol. . 2013. 87(3). 1544-1553. Find at Google Scholar.
Bartels D, Jiang M, Zhang E, Tigges A, Sullivan J, Dorrian J, Spanks J, Ardzinski A, Nicolas O, Beda. Characterization of HCV variants in genotype 1 patients administered VX-222, a non-nucleoside polyme. 5th International Workshop of Hepatitis C Res. 2010. . . Find at Google Scholar.
Troke PJ, Lewis M, Simpson P, Gore K, Hammond J, Craig C, Westby M. . Characterization of resistance to the nonnucleoside NS5B inhibitor filibuvir in hepatitis C virus-in. Antimicrob. Agents Chemother. 2011. 56. 1331-1341. Find at Google Scholar.
Mori J, Hammond JL, Srinivasan S, Jagannatha S, van der Ryst E. . Genotypic characterization of filibuvir (PF-00868554) resistance in patients receiving four weeks co. EASL. 2010. . . Find at Google Scholar.